Merck Deploys Web-based Visualization and Data Analysis Solution Enhancing Drug Discovery Efforts
Abstract
Merck Research Laboratories (MRL), in Rahway, New Jersey, is the foundation of discovery and development on which Merck & Co., Inc. (NYSE:MRK) continues to build innovative drugs to treat a wide variety of diseases. New technology, such as High Throughput Screening (HTS), is allowing researchers to test hundreds of thousands of samples from Merck's chemical and natural product ""libraries"" to determine how they affect disease processes. Traditionally, researchers tested a few hundred samples per day. With technological advances, researchers are now able to test tens of thousands of samples per day, creating difficult challenges for monitoring and maintaining the quality and efficiency of these highly automated, high volume HTS processes. By working closely with HTS scientists, the Merck team was able to define critical data-driven issues within the S-PLUS environment.
Download